Supplementary data
Supplemental Figure 1 . Dose-dependent growth profiles obtained by treating yeast cells with statins. The same number of W303 wildtype cells were supplemented with pravastatin (A), simvastatin (B), atorvastatin (C), and rosuvastatin (D) at different concentrations. In E the statin concentrations chosen for this study.
NT indicates non-treated. The simvastatin was excluded in this study because of its toxicity. Supplemental Figure 2 . The petite phenotype refers to the size of a S. cerevisiae colony with rearrangements (rho -) or the lack of mitochondrial DNA (rho°). Consequently, the absence of respiration results in a small colony compared with normal size colony with functional mitochondria. Moreover, when the wild type yeast has a ade2genotype, wild type colonies are red because of the accumulation of the Ade2 substrate, one enzyme of the adenine biosynthetic pathway. This pathway has an Ade2 upstream mitochondrial step, which is nonfunctional in petites, resulting in colonies with a white colour. The visualization of red/white colonies facilitates the screening of petites production. YPD, complete medium with glucose as carbon source. YPG, complete medium with glycerol as only respirable carbon source. W303 wild type cells, with or without statin, were plated on YPD (left) and after three days replica plated in YPG plates (right). The petites colonies (white) were not able to grow with glycerol as carbon source as indicated by white arrows, as an example.
To know if the mitochondrial DNA is rearranged (rho -) or absent (rho°), DAPI staining was performed. Figure 5 . The presence of ergosterol in the medium allows wild type cells treated with statins to maintain mitocondrial DNA, coupled with a partial restoration of wild type tubular mitochondrial morphology. The wild type strain transfomed with mitoGFP and treated with statins was grown in early exponential phase in glucose medium supplemented with 0,5mg/ml ergosterol (YPDE), stained with DAPI and visualized with fluorescence microscopy. As a control, in W303 rho° strain, devoid of mitDNA, only the nuclear DNA was observed. Bar: 2 µm. Figure 7 . Growth curves of the C25T mutant, a MELAS model, treated with statins. Statins treatments slightly affect the fitness of cells in the exponential growth phase at the concentrations used. Pravastatin induces a lag phase in early exponential phase. Data are the average of two independent experiments. 
